title: Managing ADHD in general practice. N of 1 trials can help!
abstract: OBJECTIVE
  To pilot single patient trials designed to improve decision making about stimulant use for attention deficit hyperactivity disorder (ADHD) in general practice.
  
  
  METHODS
  Patients previously stabilised on dexamphetamine were enrolled from a general practice. Each undertook a six week same patient randomised, double blind, placebo controlled crossover comparison of dexamphetamine with placebo for ADHD. Rating scales were completed weekly by self, parent and teacher.
  
  
  RESULTS
  Three of the four patients were clear responders to dexamphetamine (including a noncompleter, as his results still demonstrated a clear response). The results were clinically useful in each case. Management was confirmed for three patients and changed for one (who ceased dexamphetamine).
  
  
  CONCLUSIONS
  Prescribing stimulant medications only to children with diagnosed ADHD and who are found to respond, limits use of these worrisome drugs to those who will respond, and minimises their use in those who will not benefit.
authors.affiliation: Centre for General Practice, University of Queensland. c.duggan@spmed.uq.edu.au
authors.forename: C M
authors.initials: CM
authors.lastname: Duggan
authors.forename: G
authors.initials: G
authors.lastname: Mitchell
authors.forename: C J
authors.initials: CJ
authors.lastname: Nikles
authors.forename: P P
authors.initials: PP
authors.lastname: Glasziou
authors.forename: C B
authors.initials: CB
authors.lastname: Del Mar
authors.forename: A
authors.initials: A
authors.lastname: Clavarino
mesh_terms: D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D018592:Cross-Over Studies; D003913:Dextroamphetamine / Q000627:therapeutic use*; D004311:Double-Blind Method; D005194:Family Practice; D006801:Humans; D008297:Male
chemical_list: D000697:Central Nervous System Stimulants; D003913:Dextroamphetamine